1. Home
  2. CMP vs DRUG Comparison

CMP vs DRUG Comparison

Compare CMP & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Compass Minerals Intl Inc

CMP

Compass Minerals Intl Inc

HOLD

Current Price

$21.73

Market Cap

1.0B

ML Signal

HOLD

Logo Bright Minds Biosciences Inc.

DRUG

Bright Minds Biosciences Inc.

HOLD

Current Price

$71.32

Market Cap

707.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMP
DRUG
Founded
1993
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Pharmaceuticals and Biotechnology
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
707.1M
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
CMP
DRUG
Price
$21.73
$71.32
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$21.50
$124.00
AVG Volume (30 Days)
379.5K
82.6K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.85
N/A
P/E Ratio
$52.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.60
$23.18
52 Week High
$27.00
$123.75

Technical Indicators

Market Signals
Indicator
CMP
DRUG
Relative Strength Index (RSI) 38.19 35.56
Support Level $20.58 $49.47
Resistance Level $26.40 $91.00
Average True Range (ATR) 1.14 4.55
MACD -0.31 -1.24
Stochastic Oscillator 12.72 9.05

Price Performance

Historical Comparison
CMP
DRUG

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: